North Growth Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.5M | Buy |
30,000
+4,000
| +15% | +$1.48M | 1.48% | 26 |
|
|
2026
Q1 | $7.55M | Buy |
26,000
+4,000
| +18% | +$1.31M | 1.16% | 33 |
|
|
2025
Q4 | $7.83M | Hold |
22,000
| – | – | 1.22% | 36 |
|
|
2025
Q3 | $7.13M | Hold |
22,000
| – | – | 1.24% | 34 |
|
|
2025
Q2 | $8.64M | Sell |
22,000
-6,000
| -21% | -$2.41M | 1.62% | 27 |
|
|
2025
Q1 | $12.1M | Hold |
28,000
| – | – | 2.55% | 13 |
|
|
2024
Q4 | $10.2M | Hold |
28,000
| – | – | 1.94% | 22 |
|
|
2024
Q3 | $14.6M | Hold |
28,000
| – | – | 2.73% | 9 |
|
|
2024
Q2 | $15.2M | Hold |
28,000
| – | – | 3% | 9 |
|
|
2024
Q1 | $14.5M | Hold |
28,000
| – | – | 2.77% | 8 |
|
|
2023
Q4 | $13.3M | Hold |
28,000
| – | – | 2.84% | 9 |
|
|
2023
Q3 | $12.3M | Sell |
28,000
-1,000
| -3% | -$454K | 2.73% | 11 |
|
|
2023
Q2 | $12.8M | Hold |
29,000
| – | – | 2.63% | 13 |
|
|
2023
Q1 | $13.3M | Sell |
29,000
-3,000
| -9% | -$1.43M | 2.83% | 11 |
|
|
2022
Q4 | $16.4M | Hold |
32,000
| – | – | 3.72% | 6 |
|
|
2022
Q3 | $14.5M | Hold |
32,000
| – | – | 3.62% | 4 |
|
|
2022
Q2 | $15.4M | Sell |
32,000
-7,000
| -18% | -$3.46M | 3.57% | 8 |
|
|
2022
Q1 | $19.3M | Hold |
39,000
| – | – | 3.57% | 7 |
|
|
2021
Q4 | $18.1M | Hold |
39,000
| – | – | 3.02% | 10 |
|
|
2021
Q3 | $14.6M | Hold |
39,000
| – | – | 2.57% | 13 |
|
|
2021
Q2 | $14.9M | Hold |
39,000
| – | – | 2.42% | 13 |
|
|
2021
Q1 | $14M | Hold |
39,000
| – | – | 2.47% | 13 |
|
|
2020
Q4 | $12.5M | Sell |
39,000
-3,000
| -7% | -$921K | 2.56% | 12 |
|
|
2020
Q3 | $11.2M | Buy |
42,000
+9,000
| +27% | +$2.42M | 2.47% | 17 |
|
|
2020
Q2 | $8.68M | Sell |
33,000
-1,000
| -3% | -$267K | 2.08% | 22 |
|
|
2020
Q1 | $7.7M | Buy |
34,000
+4,000
| +13% | +$1.09M | 2.16% | 23 |
|
|
2019
Q4 | $9.19M | Hold |
30,000
| – | – | 2.06% | 25 |
|
|
2019
Q3 | $7.3M | Buy |
30,000
+8,000
| +36% | +$2.19M | 1.76% | 31 |
|
|
2019
Q2 | $6.16M | Hold |
22,000
| – | – | 1.52% | 30 |
|
|
2019
Q1 | $6.26M | Sell |
22,000
-8,000
| -27% | -$2.31M | 1.67% | 29 |
|
|
2018
Q4 | $7.83M | Hold |
30,000
| – | – | 2.19% | 21 |
|
|
2018
Q3 | $8.17M | Sell |
30,000
-6,000
| -17% | -$1.56M | 2.07% | 27 |
|
|
2018
Q2 | $8.48M | Sell |
36,000
-5,000
| -12% | -$1.16M | 2.14% | 26 |
|
|
2018
Q1 | $9.05M | Hold |
41,000
| – | – | 2.33% | 18 |
|
|
2017
Q4 | $9.27M | Buy |
+41,000
| New | +$8.73M | 2.43% | 19 |
|
Other funds holding ELV
North Growth Management's ELV Position: Q2 2026 in Review
North Growth Management increased its Elevance Health (ELV) stake by 15% in Q2 2026, buying an estimated $1.48M and bringing the position to 30,000 shares worth $11.5M. The position accounts for 1.48% of the portfolio, ranked #26.
North Growth Management first reported a position in ELV in Q4 2017 and has held it in 35 quarters since. The position peaked at $19.3M in Q1 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- North Growth Management held 30,000 shares of Elevance Health worth $11.5M as of Q2 2026.
- North Growth Management bought 4,000 Elevance Health shares in Q2 2026, an estimated $1.48M.
- Elevance Health made up 1.48% of North Growth Management's portfolio in Q2 2026, its #26 holding.
- North Growth Management first reported a position in Elevance Health in Q4 2017 and has held it in 35 quarters since.
- North Growth Management's Elevance Health position peaked at $19.3M in Q1 2022.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on North Growth Management's 13F filing for Q2 2026, filed 22 Jul 2026.